ArticleClinical and translational medicine2024

A subtype of cancer-associated fibroblast expressing syndecan-2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer.

Ji-Yong Sung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.